SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-046984
Filing Date
2024-04-23
Accepted
2024-04-23 16:39:09
Documents
1
Period of Report
2024-04-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7270
  Complete submission text file 0000950170-24-046984.txt   9018
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 1040 WEST GEORGIA STREET SUITE 1030 VANCOUVER A1 V6E 4H1
Business Address
Wan Jerry (Reporting) CIK: 0001828041 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 24865352